Cefazolin Qilu 1 g prašak za otopinu za injekciju/infuziju
Name | Cefazolin Qilu 1 g prašak za otopinu za injekciju/infuziju |
---|---|
Marketing Authorisation Number | HR-H-572695905 |
Active Substance | cefazolinnatrij |
Composition | jedna bočica sadrži 1 g cefazolina (u obliku cefazolinnatrija) |
Pharmaceutical Form | Prašak za otopinu za injekciju / infuziju |
Manufacturer | Kymos S.L., Cerdanyola del Valles, Barcelona, Španjolska MIAS Pharma Limited, Portmarnock, Irska Tillomed Malta Limited, San Gwann, Malta |
Marketing Authorisation Holder | Qilu Pharma Spain S.L., Paseo de la Castellana 40, planta 8, Madrid, Španjolska |
Marketing Authorisation Date | 16.03.2023 |
MA Period of Validity | 16.03.2028 |
Classification Number | UP/I-530-09/22-01/263 |
Registration Number | 381-12-01/70-23-07 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | J01DB04 |
SmPC | download |
PL | download |
Public Assessment Report | download |
Summary of risk management plan | download |